🎉 Unveiling Cmbio®: A New Brand Unifying Leaders in Microbiome and Metabolomics Science🔬 We are proud to announce the formation of Cmbio®, our new brand that unifies Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba's Research Services. Cmbio® establishes itself as a leader in global multi-omics platforms, delivering innovative solutions across human, animal, and planetary health sectors. As the first microbiome service and technology company with a global presence, Cmbio® is equipped with state-of-the-art multi-omics laboratories and boasts advanced bioinformatics, applied AI, and integrative systems biology expertise. Our GxP Standards-compliant and highly scalable software platforms are designed to analyze and visualize extensive data from microbiome studies, setting a new benchmark in the field. "By broadening our focus from ‘clinical’ to ‘bio,’ the new Cmbio brand is a better reflection of the scope of our activities and our commitment to enable microbiome science in addressing critical global health and sustainability challenges," says Anders Grøn, CEO at Clinical Microbiomics. The inception of Cmbio® addresses critical industry challenges such as the standardization of sampling, data generation, and analysis in microbiome research. Our aim is to enhance the reliability and comparability of global studies through accelerated standardization. "Our enterprise solutions combine GxP-certified laboratories for multi-omics data generation with a robust software platform that simplifies bioinformatics for researchers, enabling faster discoveries and innovations" remarks Manoj Dadlani, CEO at CosmosID. As Cmbio®, we are dedicated to advancing scientific understanding and innovations in health and well-being for all life on our planet. Visit https://hubs.li/Q02YHK-y0 to find out more
Om os
Cmbio®, is at the forefront of the human, animal, and planetary health—microbiome science. Formed from the unification of industry leaders like Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba’s Research Services, Cmbio® stands as the first global microbiome service and technology company equipped with state-of-the-art multi-omics laboratories and advanced bioinformatics. Our mission is to demystify the complex interplay of the microbiome and its vast influence on health and disease. By integrating applied AI with integrative systems biology, Cmbio® offers unparalleled insights and enterprise solutions that accelerate the pace of discovery and innovation in microbiome research. With GxP-compliant facilities and a robust, scalable software platform, Cmbio® is uniquely positioned to standardize microbiome analysis, ensuring reliability and comparability across global studies. We are committed to advancing scientific understanding and enhancing well-being across all life on our planet. Connect with Cmbio®: Explore how we're making strides in microbiome research and offering cutting-edge solutions to meet the grand challenges of health and sustainability.
- Websted
-
www.cmbio.io
Eksternt link til Cmbio
- Branche
- Bioteknologi
- Virksomhedsstørrelse
- 51-200 medarbejdere
- Hovedkvarter
- Copenhagen, Capital Region
- Type
- Privat
- Grundlagt
- 2015
- Specialer
- Microbiome analysis, Microbiome science, Microbiomics, Bioinformatics, NGS Sequencing, Shotgun metagenomics, Microbiomics, Microbiota analysis og Microbiome analysis services
Beliggenheder
-
Primær
Fruebjergvej 3
Copenhagen, Capital Region 2100, DK
Medarbejdere hos Cmbio
Opdateringer
-
Missed our live webinar last week with Britton Strickland, Ph.D. and Gustav Lindved? No worries! You can catch all the insights and expert tips on demand anytime thanks to our friends at Revvity. 🎥✨ Dive into the discussion and see what you missed! Watch it here: https://hubs.li/Q02XnsfV0 #WebinarOnDemand #LearnWithUs #microbiome #metagenomics #software
-
🎉 2 Exciting Announcements! We're thrilled to report the opening of our new US metabolomics laboratory and the expansion of our Short Chain Fatty Acid (SCFA) Panel! To celebrate, we're offering limited-time discounts on our expanded Short-Chain Fatty Acid (SCFA) Panel: 🌟Up to 20% off our SCFA panel for orders before year-end 🌟Up to 40% off the SCFA panel + metagenomics analysis combo Get in touch to take advantage of our offers: https://hubs.li/Q02Xhj720 🔬 Our enhanced SCFA panel now includes groundbreaking new targets such as 3-Methyl pentanoic acid and 2-Methylbutyric acid (plus many more!), key in reducing inflammation and supporting cardiovascular health. The new additions to our panel, the branched short-chain fatty acids (BCFAs), are crucial for deepening our understanding of the gut microbiome's impact on overall health. These BCFAs, including 2-methylbutyric acid, play significant roles in reducing inflammation and oxidative stress, potentially lowering dementia risks and promoting cardiovascular health. By expanding your panel to include these BCFAs, your research into the intricate interplay between diet, microbiota, and host health becomes more detailed, empowering more precise studies into how the gut microbiome influences various health conditions. 🌍 Available now in both our EU and US facilities, seize this perfect opportunity to advance your microbiome research with cutting-edge precision at great discounts! #Metabolomics #MicrobiomeResearch #HealthInnovation #LabOpening #ScienceNews
-
🍿Join us on October 30th for a live demo of CosmosID-HUB 🍿 📊 What to Expect: - Learn how NEXTFLEX™ WGS library kit users can access complimentary analysis credits - Explore workflows like CHAMP for human microbiome research and Kepler for non-human/environmental studies - Gain insights into applications across clinical, environmental, and agricultural sectors, including poultry health - Learn how to leverage linear models and other advanced statistics - 'Explore More' Q&A session In this session, we'll dive deep into the HUB’s intuitive interface and analytical capabilities. Speakers: 🧑🔬 Britton Strickland, Ph.D. (Field Application Scientist) 🧑🔬 Gustav Lindved (Senior Scientific Product Manager) Don’t miss out on this opportunity to see how advanced bioinformatics can unlock the full potential of your metagenomic data! Save your spot for October 30th now 👉https://hubs.li/Q02TdK2X0 #Bioinformatics #Metagenomics #Sequencing #ResearchInnovation #Webinar #MicrobiomeResearch
Advanced, End-To-End Shotgun Metagenomics Workflows
event.on24.com
-
CHAMP: A New Benchmark in Human Metagenomic Profiling We’re proud to announce that our human metagenomic profiler, CHAMP, has been published in Frontiers in Microbiology! CHAMP employs a cutting-edge, sample-specific gene modeling approach that significantly reduces false positives, outperforming all other profilers in head-to-head comparisons. Explore the paper here: https://hubs.li/Q02V3fNV0 Interested in trying CHAMP for your own research? Get in touch with us, or access CHAMP today via the CosmosID-Hub: https://hubs.li/Q02V3fyX0 #Microbiome #Metagenomics #Research #Innovation
-
🍿Unlock The Full Potential Of Your Shotgun Metagenomic Sequencing Data! 🍿 Join us and our partners, Revvity, on October 30th for an insightful webinar on how to transform raw metagenomic sequencing data into meaningful insights using the CosmosID-HUB platform. Whether you’re in clinical, environmental, or agricultural research, this session is for you! 🎓 What You’ll Learn 🎓 - Seamlessly explore and analyze your data with analysis credits for NEXTFLEX™ WGS library kit users. - Dive into specialized workflows like CHAMP for human microbiome research and KEPLER for environmental studies - Discover how the CosmosID-HUB’s advanced tools provide high-resolution taxonomic profiling, functional characterization, and cohort comparative analysis - Explore More Q&A session Speakers: 🧑🔬 Britton Strickland, Ph.D. (Field Application Scientist) 🧑🔬 Gustav Lindved (Senior Scientific Product Manager) Don’t miss out on this opportunity to see how advanced bioinformatics can unlock the full potential of your metagenomic data! Save your spot for October 30th now 👉https://hubs.li/Q02TdDpk0 #Bioinformatics #Metagenomics #Sequencing #ResearchInnovation #Webinar #MicrobiomeResearch
Advanced, End-To-End Shotgun Metagenomics Workflows
event.on24.com
-
Exciting News!📰 Clinical Microbiomics is thrilled to announce a significant step in our global expansion. As part of a new agreement with Microba Life Sciences Ltd., Microba’s Research Services business unit will join the Clinical Microbiomics family. We are excited to bring our multi-omics services and integrative systems biology expertise to even more clients around the globe. Anders Grøn, CEO of Clinical Microbiomics: “Microba has built an excellent reputation and shares our commitment to scientific and quality excellence. This collaboration accelerates our expansion into Asia Pacific, allowing us to elevate the role of microbiome science across human and planetary health.” We are also pleased to welcome key Microba research services staff in Australia, Singapore, and Korea, providing local expertise to our clients in the region. Mark P., Director of Business Development APAC and Emerging Markets: “We are excited to bring Clinical Microbiomics’ state-of-the-art multi-omics laboratories, advanced bioinformatics, applied AI, and integrative systems biology expertise to our clients in the region. The strong scientific culture of Microba merges seamlessly with the professionalism and scientific rigor of our team.” Read more: https://lnkd.in/dvX6EeRX #GlobalExpansion #MicrobiomeScience #AsiaPacific #BiotechInnovation #ClinicalMicrobiomics
-
🌍🔬Emerging trends in the Microbiome for 2024! 🔬🌍 The microbiome industry is rapidly evolving, with groundbreaking trends and insights set to shape healthcare, agriculture, and nutrition in 2024 📈 At Clinical Microbiomics, we've compiled 40 key statistics and trends that highlight the transformative impact of microbiome research. From novel therapeutic approaches to cutting-edge technological advancements, these insights will help you stay ahead in this dynamic field. 👉 Check out our latest blog post; 40 Microbiome Statistics and Trends Changing the Industry in 2024. https://hubs.li/Q02S7-H80 #Microbiome #HealthcareInnovation #MicrobiomeResearch #CosmosID #BiotechTrends #MicrobiomeTherapeutics #2024Trends #LifeSciences #FutureOfHealthcare
40 Microbiome Statistics Changing the Industry in 2024 | CosmosID
https://www.cosmosid.com
-
Join us at the Animal AgTech Innovation Summit where we’ll be showcasing our microbiome and omics services tailored to the agtech sector. We’re passionate about driving innovation in agriculture, animal health, and aquaculture through advanced microbiome research. Whether you’re exploring methane reduction strategies, AMR surveillance, feed efficiency, or improving animal and crop health, Anaïs Guebey and Mads Toft Søndergaard are excited to discuss how our multi-omics services can help you achieve your research goals. Stop by and learn how our long-read sequencing services can help you unlock the microbiome and provide efficient strain characterization or explore our full suite of omics offerings! #AgTech #Microbiome #Metagenomics #AnimalHealth #Sustainability
-
Fast and cost-effective long-read sequencing of microbial genomes. Long-read nanopore sequencing has advanced significantly. Using the latest Q20+ chemistry, high-quality bacterial genomes are obtainable without short-read or reference-based polishing. These high-quality (QV50+) and contiguous genomes provide unprecedented biological insight, even across challenging regions like repetitive elements and structural variants. In a recent co-authored publication in Nature Methods (https://hubs.li/Q02R2_CR0), we demonstrate how Oxford Nanopore Technologies enables this leap forward. At Clinical Microbiomics / CosmosID/ DNASense, our sample-to-answer workflows cover: - DNA extraction, library preparation, sequencing and quality control - de novo genome assembly, functional gene annotation and whole-genome classification - Structural variation analysis, including repetitive and mobile elements - Core genome SNP analysis for ultra-high resolution phylogenetic comparisons - Methylation pattern analysis - GRAS regulatory genomic reporting for probiotic strains Our genomics service offers fast turnaround time (down to 72 h) and unmatched accuracy, making it the ideal choice for research and regulatory applications. Contact us to learn how our long-read sequencing solutions can accelerate your microbial genomics research: https://hubs.li/Q02R2YD60
Oxford Nanopore R10.4 long-read sequencing enables the generation of near-finished bacterial genomes from pure cultures and metagenomes without short-read or reference polishing - Nature Methods
nature.com